Robert J. Deans
Corporate Officer/Principal chez Kent State University (Ohio)
Profil
Robert J.
Deans is currently the Chairman of Regenerative Medicine at Kent State University.
Previously, he held positions as Director of Research & Development at Baxter International, Vice President of Research at Osiris Therapeutics, and Senior Vice President of Regenerative Medicine at Athersys, Inc. He also served as Senior Vice President of Regenerative Medicine at BTHC VI, Inc. and Executive Vice President of Regenerative Medicine at Athersys, Inc. Deans received his undergraduate degree from Massachusetts Institute of Technology and his doctorate from the University of Michigan.
Postes actifs de Robert J. Deans
| Sociétés | Poste | Début |
|---|---|---|
| Kent State University (Ohio) | Corporate Officer/Principal | - |
Anciens postes connus de Robert J. Deans
| Sociétés | Poste | Fin |
|---|---|---|
| BTHC VI, Inc. | Corporate Officer/Principal | 06/09/2007 |
Athersys, Inc. /Old/
 Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Corporate Officer/Principal | 01/06/2007 |
| OSIRIS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2001 |
| BAXTER INTERNATIONAL INC. | Directeur Technique/Scientifique/R&D | 01/01/1998 |
| ATHERSYS, INC. | Corporate Officer/Principal | - |
Formation de Robert J. Deans
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| ATHERSYS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| BTHC VI, Inc. | Finance |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
Athersys, Inc. /Old/
Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Health Technology |